⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL573927 | 1.00 | — | — | |
| SCHEMBL3325667 | 1.00 | — | — | |
| Bromide SCHEMBL6632314 | 0.98 | FFAR3 (0.39) | — | |
| Bromide SCHEMBL14659502 | 0.98 | FFAR3 (0.39) | — | |
| Hydrochloric Acid SCHEMBL16798066 | 0.98 | FFAR3 (0.39) | — | |
| Water SCHEMBL25175984 | 0.98 | FFAR3 (0.39) | — | |
| Hydrochloric Acid SCHEMBL17393208 | 0.98 | FFAR3 (0.39) | — | |
| Hydrochloric Acid SCHEMBL17393207 | 0.98 | FFAR3 (0.39) | — | |
| SCHEMBL25372775 | 0.93 | FFAR3 (0.39) | — | |
| SCHEMBL53553 | 0.93 | FFAR3 (0.39) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 823 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122070294-A | Stable vitreous material based on histidine, arginine and glutamic acid amino acids | 阵序补丁有限公司 | 2026-05-19 | — | — | CN | claimed |
| CN-122055375-A | Compounds and methods for treating central nervous system disorders | 美国西北大学 | 2026-05-15 | — | — | CN | claimed |
| EP-4727654-A1 | DLL3 TARGETING PEPTIDES AND CONSTRUCTS THEREOF | Mariana Oncology Inc. (US) | 2026-04-22 | — | — | EP | claimed |
| EP-4727653-A1 | DLL3 TARGETING PEPTIDES AND CONSTRUCTS THEREOF | Mariana Oncology Inc. (US) | 2026-04-22 | — | — | EP | claimed |
| EP-4727655-A1 | DLL3 TARGETING PEPTIDES AND CONSTRUCTS THEREOF | Mariana Oncology Inc. (US) | 2026-04-22 | — | — | EP | claimed |
| US-12297172-B2 | Compositions of trofinetide | NEUREN PHARMACEUTICALS LIMITED (NZ) | 2025-05-13 | — | — | US | claimed |
| WO-2025049670-A1 | COMPOUNDS AND METHODS FOR TREATING CENTRAL NERVOUS SYSTEM DISORDERS | NORTHWESTERN UNIVERSITY (US) | 2025-03-06 | — | — | WO | claimed |
| US-20250049970-A1 | DLL3 TARGETING PEPTIDES AND CONSTRUCTS THEREOF | MARIANA ONCOLOGY INC (US) | 2025-02-13 | — | — | US | claimed |
| US-20250034210-A1 | DLL3 TARGETING PEPTIDES AND CONSTRUCTS THEREOF | MARIANA ONCOLOGY INC (US) | 2025-01-30 | — | — | US | claimed |
| US-20250011368-A1 | DLL3 TARGETING PEPTIDES AND CONSTRUCTS THEREOF | MARIANA ONCOLOGY INC (US) | 2025-01-09 | — | — | US | claimed |
| US-5658928-A | ANTICOAGULANTS, ANTIINFLAMMATORY AGENTS, ANTITUMOR AGENTS,WOUND HEALING AGENTS, OSTEOPOROSIS | HOFFMANN-LA ROCHE INC. (US) | 1997-08-19 | — | — | US | claimed |
| US-5534498-A | TREATMENT OF PANCREATITIS | CORVAS INTERNATIONAL, INC. (US) | 1996-07-09 | — | — | US | claimed |
| EP-0505868-B1 | N-Acyl-alpha-aminoacids derivatives | HOFFMANN LA ROCHE (CH) | 1995-09-13 | — | — | EP | claimed |
| US-5378712-A | Antithrombosis | Hoffmann-La Roche Inc (US) | 1995-01-03 | — | — | US | claimed |
| EP-0422937-B1 | Fibrinogen receptor antagonists | MERCK & CO INC (US) | 1994-03-02 | — | — | EP | claimed |
| WO-1993000108-A1 | NOVEL INHIBITORS OF PLATELET AGGREGATION | CORVAS INTERNATIONAL, INC. (US) | 1993-01-07 | — | — | WO | claimed |
| EP-0505868-A2 | N-Acyl-alpha-aminoacids derivatives | F. HOFFMANN-LA ROCHE AG (CH) | 1992-09-30 | — | — | EP | claimed |
| US-5023233-A | Fibrinogen receptor antagonists | MERCK & CO., INC. (US) | 1991-06-11 | — | — | US | claimed |
| EP-0411833-A1 | Fibrinogen receptor antagonists | MERCK & CO. INC. (US) | 1991-02-06 | — | — | EP | claimed |
| US-4482725-A | ANGIOTENSIN CONVERTING ENZYME INHIBITOR | E. R. SQUIBB & SONS, INC. (US) | 1984-11-13 | — | — | US | claimed |